Covid19 – Pfizer to deliver 10% more doses to the US by the end of May
Pfizer Inc can deliver 10% more doses of its Covid-19 vaccine to the United States by the end of May and meet its target of supplying 300 million doses two weeks earlier than expected, Chief Executive Officer Albert Bourla said.
Separately, the company said it had conducted an assessment of the vaccines’ safety data and had found no evidence of blood clots.
Some states, such as New York, said they will use Pfizer’s vaccine in place of the J&J shot for appointments that had already been scheduled.
Pfizer’s statement comes as U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot.
Real also – US to pause use of J&J over blood clot concerns
The White House said it was confident there would be no ‘significant impact’ on the vaccination plan in the world’s hardest-hit country, where almost half of all adults have now received at least one dose.